Vytrus Biotech Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '26 May 18, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	122	64	16	13	23	-
Market Cap Growth	402.59%	294.97%	29.02%	-46.26%	-	-
Enterprise Value	120	62	16	14	23	-
Last Close Price	16.20	8.55	2.16	1.86	3.40	-
PE Ratio	42.04	22.21	15.95	23.17	38.81	-
Forward PE	-	21.98	21.98	11.97	26.21	-
PS Ratio	12.56	6.64	2.67	2.69	5.24	-
PB Ratio	11.81	6.24	2.23	2.38	4.94	-
P/TBV Ratio	22.75	12.02	5.06	7.59	14.68	-
P/FCF Ratio	42.18	22.29	9.35	16.55	38.78	-
P/OCF Ratio	31.22	16.50	8.83	13.96	22.90	-
EV/Sales Ratio	12.34	6.45	2.64	2.91	5.20	-
EV/EBITDA Ratio	35.24	18.41	13.67	22.96	30.92	-
EV/EBIT Ratio	37.89	19.79	16.34	33.82	38.42	-
EV/FCF Ratio	41.42	21.64	9.24	17.93	38.49	-
Debt / Equity Ratio	0.12	0.12	0.24	0.39	0.21	0.22
Debt / EBITDA Ratio	0.37	0.37	1.51	3.49	1.31	0.94
Debt / FCF Ratio	0.43	0.43	1.02	2.72	1.63	4.09
Net Debt / Equity Ratio	-0.21	-0.21	-0.10	0.18	0.06	-0.08
Net Debt / EBITDA Ratio	-0.65	-0.65	-0.64	1.63	0.35	-0.36
Net Debt / FCF Ratio	-0.76	-0.76	-0.43	1.27	0.43	-1.56
Asset Turnover	0.75	0.75	0.60	0.54	0.59	0.53
Inventory Turnover	1.47	1.47	1.07	0.72	1.02	1.11
Quick Ratio	2.67	2.67	2.60	1.90	0.99	1.92
Current Ratio	3.03	3.03	3.03	2.46	1.33	2.26
Return on Equity (ROE)	32.91%	32.91%	16.23%	10.85%	13.44%	11.45%
Return on Assets (ROA)	15.29%	15.29%	6.02%	2.92%	4.99%	3.82%
Return on Invested Capital (ROIC)	36.07%	39.94%	15.39%	7.17%	13.62%	11.25%
Return on Capital Employed (ROCE)	24.50%	24.50%	10.00%	4.90%	9.00%	6.40%
Earnings Yield	2.38%	4.50%	6.27%	4.32%	2.58%	-
FCF Yield	2.37%	4.49%	10.70%	6.04%	2.58%	-
Buyback Yield / Dilution	0.10%	0.10%	-11.71%	-	-	-0.43%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.